LAFAYETTE MEDICAL APPROACH LLC
NPI 1366789158
Clinic/Center - Methadone in New York, NY

NPI Status: Active since January 14, 2013

Contact Information

233 LAFAYETTE ST
GROUND FLOOR
NEW YORK, NY
ZIP 10012
Phone: (212) 431-6177
Fax: (212) 966-7160

Get Directions Write a Review

  • Organization
  • Clinic/Center
  • Methadone
  • CLIA Number: 33D2173065
  • CLIA Cert. Type: Physician Office
  • CLIA Exp. Date: 03-26-2027

About LAFAYETTE MEDICAL APPROACH LLC

This page provides the complete NPI Profile along with additional information for Lafayette Medical Approach Llc, a provider established in New York, New York operating as a Clinic/center, focusing in methadone . The healthcare provider is registered in the NPI registry with number 1366789158 assigned on January 2013. The practitioner's primary taxonomy code is 261QM2800X with license number 140110386 (NY). The provider is registered as an organization and their NPI record was last updated one year ago. The provider's . The authorized official of this NPI record is Robert Degiarde (Executive Director)

NPI
1366789158
Provider Legal Name
LAFAYETTE MEDICAL APPROACH LLC
Other Organization Name
Other Name Type
(6)
Entity Type
Organization
Location Address
233 LAFAYETTE ST GROUND FLOOR NEW YORK, NY 10012
Location Phone
(212) 431-6177
Location Fax
(212) 966-7160
Mailing Address
233 LAFAYETTE ST GROUND FLOOR NEW YORK, NY 10012
Mailing Phone
(212) 431-6177
Mailing Fax
(212) 966-7160
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
01-14-2013
Last Update Date
08-22-2025
Code Navigator

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinic/Center Methadone

Taxonomy Code
261QM2800X
Type
Ambulatory Health Care Facilities
License No.
140110386
License State
NY
Taxonomy Description
An entity, facility, or distinct part of a facility providing diagnostic, and replacement maintenance treatment services related to individuals with drug addiction.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

ROBERT DEGIARDE

Authorized Official Title
EXECUTIVE DIRECTOR
Authorized Official Phone
(122) 431-6177

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm

Medication Assisted Treatment (MAT) with methadone is a comprehensive approach to manage opioid addiction. It includes weekly methadone dispensing, substance use counseling, individual and group therapy sessions, and toxicology tests as needed, all provided by a Medicare-enrolled opioid treatment program.

This service was performed 1,224 times for 57 patients

Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

Medication Assisted Treatment is a comprehensive program for managing substance use. It includes counseling (both individual and group), along with regular toxicology testing if required. This service is provided by a Medicare-enrolled opioid treatment program.

This service was performed 56 times for 22 patients

Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure

This service provides an additional 7-day supply of methadone, a medication used to treat opioid addiction, for patients to take at home. It's provided by a Medicare-enrolled opioid treatment program. This service is billed separately from the main treatment procedure.

This service was performed 674 times for 37 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
33D2173065
Facility Type
Physician Office
Certificate Effective Date
October 04, 2019
Certificate Expiration Date
March 26, 2027
Laboratory Director
DR. RAKHSHAN M. CHIDA
Certificate Type
Certificate of Waiver
Certificate Type Description
This CLIA certificate is issued to Lafayette Medical Approach Llc to perform only waived tests. CLIA defines waived tests as simple tests with a low risk for an incorrect result. Waived tests include certain tests listed in CLIA regulations, tests cleared by the FDA for home use and tests approved by the FDA for waived status and that meet CLIA waiver criteria.

Reviews for LAFAYETTE MEDICAL APPROACH LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1366789158, we treat the final digit (8) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 62. The final step is to find the difference between that total and the next multiple of ten (70 - 62 = 8).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
3
Unchanged
Pos 3
6
Doubled → 12 → 1 + 2
Pos 4
6
Unchanged
Pos 5
7
Doubled → 14 → 1 + 4
Pos 6
8
Unchanged
Pos 7
9
Doubled → 18 → 1 + 8
Pos 8
1
Unchanged
Pos 9
5
Doubled → 10 → 1 + 0
Check
8
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 6 → 12 → 3 7 → 14 → 5 9 → 18 → 9 5 → 10 → 1

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 3 + 1 + 2 + 6 + 1 + 4 + 8 + 1 + 8 + 1 + 1 + 0 + 24 = 62

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 62 is 70. The difference is the calculated check digit.

70 - 62 = 8
This NPI is valid
The calculated check digit is 8, which matches the last digit of 1366789158.

Other Providers at the Same Location


The following 20 providers are registered at the same or a nearby location.

Clinic/Center (Methadone)
233 LAFAYETTE ST
NEW YORK, NY 10012
Clinic/Center (Rehabilitation, Substance Use Disorder)
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Mental Health)
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Mental Health)
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Mental Health)
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Social Worker
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Counselor (Addiction (Substance Use Disorder))
233 LAFAYETTE ST
NEW YORK, NY 10012
Licensed Practical Nurse
233 LAFAYETTE ST
NEW YORK, NY 10012

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1366789158, enumerated as an "organization" on January 14, 2013.

The provider is located at 233 LAFAYETTE ST GROUND FLOOR NEW YORK, NY 10012 and the phone number is (212) 431-6177.

Clinic/Center with taxonomy code 261QM2800X and a focus in Methadone.